Urginea indica and its role in psoriasis: A Review by Shiva Kameshwari, M.N. & Paramasivam, G.
Review Article                               [Kameshwari & Paramasivam, 3(12 Suppl.): Dec., 2012] 
CODEN (USA): IJPLCP                                                        ISSN: 0976-7126 
Int. J. of Pharm. & Life Sci. (IJPLS), Vol. 3, Issue 12(Suppl.): December: 2012, 
2236-2242 
2236 
 
INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES 
 
Urginea indica and its role in psoriasis: A Review 
M.N. Shiva Kameshwari and G. Paramasivam 
Department of Botany Biosystematics Laboratory, Bangalore University, Bangalore, (Karnataka) - India 
 
 
 
Abstract 
Psoriasis an inflammatory disease of the skin, non-infections.  It is an increased proliferation of the skin layers due 
to excessive division of the cell in the basal layers of the skin.  The disease is characterized by well defined plaques 
with large adherent silvery scales, associated with sever itching.  Dryness of skin and silvery scaling are symptoms.  
It is one of the most common skin disorders in humans, treatments are not available in English Medicine it is 
available in Ayurveda using Urginea indica (Liliaceae) and Chinese Herbal Medicine (CHM) has been used for 
treating psoriasis and systematic administration of one such CHM is effective in psoriasis.  Ayurveda treatments 
have no side effects reported so far when compared to English Medicine.  The present study is a review of earlier 
work and explored the currently used and the historically, used herbal remedies in the treatment of psoriasis. 
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Introduction                                                                               
Psoriasis is a common chronic inflammatory 
dermatosis.  Person of all ages may develop the 
disease.  It frequently affects the skin of the elbow, 
knees, scalp, lumbosacral areas, intergluteal cleft and 
grans penis.  The most typical lesion is a well 
demarcated, pink coloured plaque covered by loosely 
adherent scales that are characteristically silver white 
in colour person of all ages may develop the disease. 
Disease onset in early admitted due to genetic 
transmission and more than a dozen immune modifying 
biological agents. 
Internet 
Psoriasis is a chronic immune mediated disease that 
appears on the skin.  It occurs when the immune 
system sends out faulty signals that speed up the 
growth cycle of skin cells. There are 5 types of 
psoriasis plaque, guttate, inverse, pustular and 
erythrodermic. 
Psoriasis and Psoriatic arthritis (PSA) are complex 
genetic disease with environmental stimuli & genetic 
components. There has been approximately 10-30% of 
Psoriasis & patients develop PSA, since this case 
suggests that which susceptibility factor for Psoriasis 
are also susceptibility factor for Psoriasis arthritis. 
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The most common form, plaque psoriasis, is commonly 
seen as red and white hues of scaly patches appearing 
on the top first layer of the skin. 
Plaque psoriasis frequently occur on the skin of the 
elbows and knees, but can affect any area, including 
the scalp, palms of hands and soles of feet and genitals.  
Psoriasis can also cause inflammation of the joints, 
which is known as psoriatic arthritis 10 to 40% of all 
people with psoriasis have psoriatic arthritis.1 
The cause of psoriasis is not fully understood, but it is 
believed to have a genetic component and local 
psoriatic changes can be triggered by an injury to the 
skin known as the Koebner Phenomenon.  Various 
environmental factors have been suggested as 
aggravating psoriasis.  There are many treatments 
available but because of its chronic recurrent nature, 
psoriasis is a challenge to treat. 
Materials  
Bulbs of Urginea indica growing in Wellengiri hills 
Coimbatore collected by the tribals and prepare the 
medicine in the following way.  Roots of bulbs are 
removed since the roots are poisonous to psorosis 
Ayurved, Medicine.  
Ingredients  
Bulbs, Gingelly oil, Kasturi Manjal, Garlic, White 
Brassica, Castor Seeds.  2 Kg bulbs grinded to make it 
a paste, 2 litre Gingelly oil are boiled to the boiling oil 
add mixture of garlic ½ kg to this add grinded bulbs 
boil after boiling remove the vessel and add 250 gms of 
Kasturi Manjal powder cover it with Aluminium foil 
for 1 hr and after 1 hr filter the gel and expiry date is 
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180 days (6 months) and this gel has to be applied to 
the patient for 49 days.  (Data collected from the 
tribals).  
English Medicine for the treatment of Psoriasis  
Current drugs available in the market for the treatment 
of Psoriasis are corticosteroids.  These drugs reduce 
inflammation and the turn over of skin cells, and they 
suppress the immune system.  Available in different 
strengths, topical corticosteroids are usually applied to 
the skin twice a day.  Topical steroid medications are 
one of the most common treatment for mild to 
moderate psoriasis.  They reduce redness and itching 
and stop the rapid build up of dead skin cells.2 
Tar Compounds 
Crude coal tar is a by product of oil production.  It 
makes the skin more sensitive to light.  In its natural 
state it is a thick, brownish black substance that is 
messy to apply to the skin.  Refine coal tar preparation, 
many of which are available over the counter, may be 
more cosmetically acceptable, coal tar has been used 
for more than 100 years to treat psoriasis and it has few 
side effects (3 – 4). 
Anthralin 
Anthralin reduces the increases in skin cells and 
inflammation.  Anthralin is a synthetic medication that 
has an effect on enzymes in the skin cells of people 
with psoriasis.  It comes in a variety of strengths and in 
the form of an ointment, cream or paste. 
Vitamin – D 
Synthetic Vitamin D is also called calcipotriol it is a 
chemical. Cousin of vitamin D.3  It is odorless and non-
staining.5  It can be used alone but often works best in 
combination with other topical agents or phototherapy.6 
Retinoids 
These prescription medications are chemical cousins of 
Vitamin A and are used to treat a variety of skin 
conditions.7–8  Topical retinoids are synthetic forms of 
vitamin A.  Tazarotene is a synthetic retinoid 
introduced to treat mild to moderate plaque psoriasis 
and psoriasis of the scalp and nails.  Tazarotene clears 
skin more slowly than topical steroids, but has fewer 
side effects.9–10 
Traditional Chinese Medicine for the Treatment of 
Dermatologic Disorders 
Traditional Chinese Medicine (TCM) is an alternative 
method of therapy that can be administered in oral, 
topical or injectable form.s11 It emphasizes the 
importance of using many herbs that are combined in 
different formulations for each individual patient.  
Herbal medicine uses any plant part such as the root, 
bark, stem, seeds, flowers or leaves as a means for 
treatment.12–13 Herbal Medical Practioners can create 
many different formulas for different types of 
applications.  Traditional Chinese Medicine (TCM) is 
of particular significance because it is a common 
choice of patients.  TCM has been used to treat a 
variety of skin diseases, of particular interest to us is 
psoriasis.   Both topical and systematic use of herbs has 
been administered to treat psoriasis, as well as  a 
combination of herbal medications with UA-A.  This 
method is similar to psoralen – UV – A  Phototherapy.  
Although TCM’s are commonly found in topical, oral 
and photochemotherapeutic modalities some of them 
are also injectable.14 Sometimes the injectable agent 
yields better results than when used in the other forms.  
According to TCM psoriasis is subtyped into three 
main categories. “blood-heat” type “blood deficiency – 
dryness” type and “blood stasis” type.  According to 
the subtype of psoriasis the patient has, a different 
mixture of herbs is suggested.  For eg: when inflicted 
with blood stasis psoriasis the lesins are indurate and 
have little tendency to resolve spontaneously. 
 
The principle of treatment of this type of psoriasis is to 
activate the blood and eliminate the stasis.  To treat 
blood stasis psoriasis the lesions are indurate and have 
little tendency to resolve spontaneously.   
There is also purplish or dark red colour of the tongue 
with occasional petechia.  The principle of treatment of 
this type of psoriasis is to activate the blood and 
eliminate the stasis. To treat blood deficiency dryness a 
different set of herbs is considered more sutiable.15  
Among the physical manifestation, of this type is the 
appearance of the tongue chacterized by pinkish colour 
with a thin coating.  TCM and acupuncture.  It is highly 
doubtful as to whether acupuncture has any efficacy in 
a skin disorder such as psoriasis.  After interacting with 
prominent academic and clinical dermatology, pioneers 
in China, the general consensus was that acupuncture is 
not considered efficacious for treatment of skin 
diseases.16  
Natural medications such as herbal medicine are a safer 
mode of therapy because of its presumed lack of 
adverse effects.  The herbal medicine used in TCM has 
adverse systemic effects such as hepatotoxicity.  In 
addition, hyper sensitivity, hepatic toxicity and renal 
damage have all been reported in China, some of which 
have been fatal.  
Medicinal Plants with anti Psoriasis Activity 
1. Aloevera (Liliaceae) Leaves  
2. Urginea indica (Liliaceae) bulbs 
3. Capsicum annum (Solanaceac) Fruits  
4. Mahonia aquifoilum  
5. Glycyrrhiza glabra (Leguminosoe) 
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6. Matricaria recutita (Asteraceae) 
7. Calendula officinalis (compositac) 
8. Arctium lappa (Asteraceae) 
9. Azadirachta indica (Meliaceae) 
10. Momordica charantia (Curcurbitaceae) 
Classification 
1. Nonpustular  
a. Psoriasis vulgaris  
b. Psoriasis erythroderma  
2. Pustular  
a. Generalized pustular psoriasis  
b. Pustulosis palmaris  
c. Annular pustular psoriasis  
d. Acrodermatitis continua  
e. Impetigo herpetiform’s  
Additional types of psoriasis  
1. Drug induced psoriasis  
2. Inverse psoriasis  
3. Napkin psoriasis  
4. Seborrheic – like psoriasis  
Guttate psoriasis – due to streptococcal infection 
Nail psoriasis – Finger and toe nails 
Psoriatic arthritis – joints and connective tissue 
inflammation  
Severe cases of psoriasis have been shown to affect 
health related quality of life to an extent similar to the 
effects of other chronic diseases. Individuals with 
psoriasis many also feel self conscious about their 
appearance and have an poor image that stems from 
fear of public rejection and psychosexual concerns.  
Psychological distress can lead to significant 
depression and social isolation. In a 2008 National 
Psoriasis foundation survey of 426 sufferers, 71% 
reported the disease was a significant problem in 
everyday life. 
A 2009 study looked at the impact of psoriasis by using 
interviews with dermatologists and exploring patients 
view point.  It is found that in cases of mild and severe 
psoriasis, itch contributed most of the diminished 
health related quality of life (HRQOL).17 
Distribution of Psoriasis Severity 
Mild
65%
Severe
8%
Moderate
25%
Mild 
2%
 
 
Psoriasis is usually graded as mild, moderate or severe.  
Several scales exist for measuring the severity of 
psoriasis. The Psoriasis Area Severity Index (PASI) is 
the most widely used measurement tool for psoriasis.18 
Genetics 
Many genes are associated with psoriasis but it is not 
clear how those genes work together, the main value of 
genetic studies is they identify molecular mechanism 
and pathways for further study and potential drug 
targets.  Classic genome wide linkage analysis has 
identified nine locations (loci) on different 
chromosomes associated with psoriasis, within those 
loci are genes.  Mutations of those genes are commonly 
found in psoriasis. 
Immunology 
Diagnosis 
A diagnosis of psoriasis is usually based on the 
appearance of the skin, there are no special blood tests 
or diagnostic procedures.  A skin biopsy, or scraping 
may be needed to confirm the diagnosis.  Skin from a 
biopsy will show clubbed rete pegs if positive for 
psoriasis.  Another sign is that when the plagues are 
scraped, one can see pinpoint bleeding from the skin 
below. 
There are a number of different treatments for 
psoriasis.  Typically topical agents are used for mild 
disease.  Phototherapy, for moderate disease, and 
systematicagents for severe disease.25 
Topical Agents 
Bath solutions and moisturizers, mineral oil and 
petroleum jelly may help soothe affected skin and 
reduce dryness of skin.  Medicated creams and 
ointments applied directly to psoriatic plaques can help 
reduce inflammation, remove built up scale, and clear 
affected skin of plaques.  Ointments and creams 
containing coal tar, dithranol corticosteroids 
fluocinonide, vitamin D3 for Eg. Calcipotriol and 
retinoids are routinely used.  Apricus biosciences is 
currently developing psoriava, a topical cream for the 
treatment of psoriasis.  It contains calcipotriol and 
betamethansone as the active ingradients and a 
permeation enchancer DPAIP which facilitates the 
delivery of the drug into the blood stream.26  
Phototherapy  
Phototherapy (PUVA) in the form of sunlight has long 
been used.  Effectively for treatement27. wavelength of 
311 – 313 nm are most effective and special lamps 
have been developed for this applications.  The amount 
of light used is determined by a persons skin type. 
 
 
Systematic agents 
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Psoriasis that is resistant to topical treatment and 
phototherapy is treated by medications taken internally 
by pill or injection (systemic) and the patient are 
required to have regular blood and liver function tests 
because of the toxicity of the medication. 
There main types of treatements  
1. Methotrexate 
2. Cyclosporine 
3. Retinoids  
In the united kingdom in 2005 the British Association 
of dermatologists (BAD) published guildelines for use 
of biological interventions in psoriasis.26 In 2008, the 
FDA approved three new treatment  options (28) 
available to psoriasis patients 
1. Taclonex scalp, (Scalp psoriasis) 
2. Xtrae velocity excimer laser system to treat 
moderate to severe psoriasis. 
3. The biologic drug adalimumab. (brand name 
Humira) to severe psoriasis. 
Alternative Therapy 
Psoriasis symptoms can be relieved by changes in diet 
and lifestyle, low energy diets and vegetarian diets 
have improved psoriasis symptoms (4) diets 
supplemented with fish oil (Vitamin A and D).  The 
severity of psoriasis symptoms may also be influced by 
lifestyle habits related to alcohol, smoking, weight, 
stress and exercise (29). 
Another treatment is Ichthyotherapy, which is practiced 
at some spas in Turkey, Croatia, Ireland, Hungary.  
Doctor fish living in outdoor thermal pools are 
encouraged to feed on psoriasis skin, only consuming 
affected area.  This treatment has given positive results. 
Hypnotherapy may be effective for psoriasis (30). 
In UK, the Psoriasis and Psoriatic Arthritis Alliance 
(PAPAA) has funded research, carried out by the 
university of Manchester to develop a symptom 
management programme called Electronic Targeted 
Intervention for psoriasis (CTIP’s) using a modified 
cognitive behaviour therapy model. 
Cannabis 
Might treat psoriasis due to anti inflammatory 
properties of its cannabinoids (32). 
Researchers led by Yin-KU Lin of Chang Gung 
memorial hospital Taiwan reported that Indigo naturals 
a dark blue plant used in traditional Chinese medicine 
appears to be effective in treating psoriasis and the 
ointment treated lesion showed 81% improvement (33). 
Around one third of people with psoriasis report a 
family history of the disease and researchers have 
identified genetic loci associated with the conditions.  
Studies of monozygotic twins suggest a 70% chance of 
a twin developing psoriasis if the other twin has 
psoriasis.  The concordance is around 20% for 
dizygotic twins.  These findings suggest both a genetic 
predisposition and an environmental response in 
developing psoriasis (34). 
History 
Psoriasis is probably one of the longest known illnesses 
of humans.  Some scholars believe psoriasis to have 
been included among the skin conditions called tzaraat 
in the Bible (56).  In more recent times psoriasis was 
frequently described as a variety of Leprosy.  The 
Greeks used the term lepra for scaly skin conditions.  
They used the term psora to describe itchy skin 
conditions.  It became known as Willan’s lepra in the 
late 18th century when English dermatologists Robert 
Willan and Thomas Bateman differentiated it from 
other skin diseases. 
Viennese dermatologist Ferdinand Von Hebra gave the 
name psoriasis in 1841 and it is derived from the Greek 
word psora which means to itch (35). 
Historical Treatment 
The application of cat faeces to red lesions on the skin 
for Eg: was one of the earliest topical treatments 
employed in ancient Egypt.  Onions, sea salt, urine, 
goose oil and semen, wasp droppings in sycamore milk 
and soup made from vipers have all been reported as 
being ancient treatment. 
Fowler’s solution which contains a poisonous and 
carcinogenic arsenic compound was used by 
dermatologists as a treatment for psoriasis in 18th and 
19th century. 
Green rays (also called ultrasoft X-ray or Bucky rays) 
were a popular treatment of psoriasis during the middle 
of 20th century.  Sulphur was fashionable as a treatment 
for psoriasis in the Victorian and Edwardian Eras. 
Current novel therapeutic agents are designed for a 
better understanding of the immune processes involved 
in psoriasis for eg: the use of biologics, which target T-
cells and TNF inhibitors. 
Clinical research has demonstrated the integral role of 
Janus Kinase (JAK) proteins in the pathogenesis of 
psoriasis.  In 2010 two new oral JAK inhibitor drugs 
ruxolitinib and tofacitinib have shown rapid and 
promising efficacy in phase I / II trails with patients 
showing significant skin clearing within one week of 
beginning treatment (35, 36).  
Causes 
The cause of psoriasis is not fully understood.  There 
are two main hypotheses about the process that occurs 
in the development of the disease.  The first considers 
psoriasis as primarily a disorder of excessive growth 
and reproduction, of skin cells.  The second hypothesis 
sees the disease as being an immune mediate disorder 
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in which the excessive reproduction of skin cells is 
secondary to factors produced by the immune system.  
T cells (which normally help protect the body against 
infection) become active, migrate to the dermis and 
trigger and release of cytokines (tumour necrosis factor 
alpha TNF which cause inflammation and the rapid 
production of skin cells.  It is not known what initiate 
the activation of the T-cells. 
Medicines, including lithium salt, beta blockers and the 
emtimalarial drug chloroquine, have been reported to 
trigger or aggravate the disease.  Excessive alcohol 
consumption, smoking and obesity may exacerbate, 
psoriasis.20, 21 Hairspray, some face creams and hand 
lotions, can also cause psoriasis. 
Individuals suffering from the advanced effects of the 
human immunodeficiency virus, or HIV, often exhibit 
psoriasis.22 
CD4-T-Cell counts decrease with the progression of 
HIV, psoriasis Worsens.23  In addition, HIV is typically 
characterized by a strong Th2 Cytokine profile, 
whereas psoriasis is characterized by a strong Th 1 
secretion pattern.24  It is hypothesized that the 
diminished CD4-T –Cell presence causes an 
overactivation of CD8-T cells which are responsible 
for the exacerbation of psoriasis in HIV positive 
patients. Psoriasis occurs more likely in dry skin than 
oily or well moisturized skin. 
The immune system is thought to play a major role.  
The “Master Switch”  that turns on psoriasis is still a 
mystery. Oral medications available are  
1. Acitretin  
2. Cyclosporine  
3. Methotrexate  
Injections  
Psoriasis drugs are called biologics alefacept (amevive) 
adalimubab (Humira) infliximab (Remicade) Etaner 
cept (Enbrel) and Ustekinumab and these are expensive 
medications.  Some of the biologics manufacturers 
have patient assistance programme to help with 
financial issues. 
Future Target 
Ongoing research is needed to decipher the ultimate 
underlying of botanicals in psoriasis treatment is 
needed. 
Conclusion 
Drug discovery in ancient times was largely based on 
clinical practices.  Many drugs presently described by 
physicians are either directly isolated from plants or are 
artificially modified versions of natural products.  
Scientists are looking for lead compounds with specific 
structures and pharmacological effects often from 
natural sources.  The transition from traditional to 
empirical and to molecular screening will certainly 
increase probability of discovering new leads and drug 
candidates from natural products.  So natural products 
are beneficial for the treatment of psoriasis without any 
side effects and plants are used for the search of new 
antipsoriatic drug development and formulations. 
High intake of quercetin and other flavonoids from 
wild onion and cultivated onion has been shown to 
decrease risk of atherosclerosis in a epidemiologic 
study in the united states. 
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